Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 13Leiomyoma 8Menorrhagia 7Prostatic Neoplasms 2Osteoporosis 2Neoplasm Metastasis 2Hyperandrogenism 2Vaginitis 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Pregnancy Complications 1Postmenopausal Vaginal Atrophy 1Neoplasms 1Infertility, Female 1Infertility 1Hot Flashes 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Endometriosis 1Coronary Disease 1Cardiovascular Diseases 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1Anemia 1Anatomic Stage III Breast Cancer AJCC v8 1Abortion, Spontaneous 1

Interventions

relugolix 2Metformin 2ulipristal acetate 1Uterine Myomectomy 1Tablets 1Surgical Procedures, Operative 1Pregnancy 1Observation 1Norethindrone Acetate 1Estradiol 1Eating 1Cari-D-Tect 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pregnancy Complications × Estradiol × Clear all
NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡